Study on Indomethacin-responsive Headaches

Headache, Migraine Clinical Trial

Official title:

Non Interventional Study on Indomethacin-responsive Headaches

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03967483
• Other study ID #: 2019-A00406-51
• Status: Not yet recruiting
• Start date: June 1, 2019
• Est. completion date: June 1, 2021

Study information

• Verified date: May 2019
• Source: French Society for the Study of Migraine Headache
• Contact: Anne DONNET
• Phone: 0491384340
• Email: Anne.DONNET[@]ap-hm.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Description of modalities concerning the patient care of headaches sensible to indometacine.

Description:

Description of clinical profile, treatment of crisis and background treatment

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: June 1, 2021
• Est. primary completion date: June 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches

• patient who are taking indometacine

• patient with written consent form

Exclusion Criteria:

• patient under 18 years

• pregnant woman or breastfeeding patient

• patient who refuses to participate

Related Conditions & MeSH terms

• Headache
• Headache, Migraine
• Migraine Disorders

Intervention

Drug:
• Indometacin
patient who are taken indomatacin for headaches and migraine

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Anne Ducros

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Description of headaches sensible to indometacine	Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.	24 monthes